Concepedia

Rebecca E. Wrishko

RE

Statistics

Publications

20

Citations

1.2K

H-Index

18

Active since

1997

Affiliations

Eli Lilly (United States)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Daiichi Sankyo (United States)

University of British Columbia

Daiichi Sankyo (United Kingdom)

Rebecca E. Wrishko is an author at Eli Lilly (United States) specializing in pharmacology, clinical pharmacology, and pharmacokinetics.

ORCID

Publications per year

1997–2022

20

Publications

20

Tadalafil pharmacokinetics in healthy subjects

S. Thomas Forgue, Beverley Patterson, Alun Bedding et al. · British Journal of Clinical Pharmacology · 2005 · 283 citations · Full text

, , +15

Pharmacokinetic Interaction Between Tadalafil and Bosentan in Healthy Male Subjects

Rebecca E. Wrishko, Jasper Dingemanse, Albert S. Yu et al. · The Journal of Clinical Pharmacology · 2008 · 116 citations

, , +16

Population Pharmacokinetic Analyses to Evaluate the Influence of Intrinsic and Extrinsic Factors on Exposure of Prasugrel Active Metabolite in TRITON‐TIMI 38

Rebecca E. Wrishko, C. Steven Ernest, David S. Small et al. · The Journal of Clinical Pharmacology · 2009 · 83 citations

, , +17

Prasugrel pharmacokinetics and pharmacodynamics in subjects with moderate renal impairment and end-stage renal disease

D. S. Small, Rebecca E. Wrishko, C. Steven Ernest et al. · Journal of Clinical Pharmacy and Therapeutics · 2009 · 73 citations

, , +16

On-the-Road Driving Performance the Morning after Bedtime Use of Suvorexant 20 and 40 mg: A Study in Non-Elderly Healthy Volunteers

Annemiek Vermeeren, Hong Sun, Eric Vuurman et al. · SLEEP · 2015 · 73 citations · Full text

, , +13

1–5 of 20